Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has become standard care for the surgical treatment of Parkinson’s disease (PD). Reliable interpretation of microelectrode recording (MER) data, used to guide DBS implantation surgery, requires expert electrophysiological evaluation. Recent efforts have endeavored to use electrophysiological signals for automatic detection of relevant brain structures and optimal implant target location.
The authors conducted an observational case-control study to evaluate a software package implemented on an electrophysiological recording system to provide online objective estimates for entry into and exit from the STN. In addition, they evaluated the accuracy of the software in selecting electrode track and depth for DBS implantation into STN, which relied on detecting changes in spectrum activity.
Data were retrospectively collected from 105 MER-guided STN-DBS surgeries (4 experienced neurosurgeons; 3 sites), in which estimates for entry into and exit from the STN, DBS track selection, and implant depth were compared post hoc between those determined by the software and those determined by the implanting neurosurgeon/neurophysiologist during surgery.
This multicenter study revealed submillimetric agreement between surgeon/neurophysiologist and software for entry into and exit out of the STN as well as optimal DBS implant depth.
The results of this study demonstrate that the software can reliably and accurately estimate entry into and exit from the STN and select the track corresponding to ultimate DBS implantation.
Correspondence John A. Thompson: University of Colorado School of Medicine, Aurora, CO. email@example.com.
INCLUDE WHEN CITING Published online May 18, 2018; DOI: 10.3171/2017.12.JNS171964.
J. A. Thompson and S. Oukal have contributed equally to this work.
Disclosures Dr. John Thompson reports receiving funding from Alpha Omega for this study. Salam Oukal is an employee of Alpha Omega. Dr. Hagai Bergman reports receiving funding from Alpha Omega and serving as a consultant for Alpha Omega. Dr. Steven Ojemann reports receiving an honorarium from Alpha Omega for a presentation and serving as a consultant to both Alpha Omega and Medtronic. Dr. Adam Hebb reports a consultant relationship with Alpha Omega. Dr. Sara Hanrahan reports receiving funding from Alpha Omega for this study. Dr. Zvi Israel reports serving as a consultant for Alpha Omega. Dr. Aviva Abosch reports a consultant relationship with Medtronic, receipt of clinical or research support (for study described) from Alpha Omega, and receipt of an honorarium from Alpha Omega for a presentation.
MalletLSchüpbachMN’DiayeKRemyPBardinetECzerneckiV: Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci U S A104:10661–106662007
NovakPDanilukSElliasSANazzaroJM: Detection of the subthalamic nucleus in microelectrographic recordings in Parkinson disease using the high-frequency (> 500 Hz) neuronal background. Technical note. J Neurosurg106:175–1792007
Pinzon-MoralesRDOrozco-GutierrezAACastellanos-DominguezG: Novel signal-dependent filter bank method for identification of multiple basal ganglia nuclei in Parkinsonian patients. J Neural Eng8:360262011
Raucher-ChénéDCharrelCLde MaindrevilleADLimosinF: Manic episode with psychotic symptoms in a patient with Parkinson’s disease treated by subthalamic nucleus stimulation: improvement on switching the target. J Neurol Sci273:116–1172008
WongSBaltuchGHJaggiJLDanishSF: Functional localization and visualization of the subthalamic nucleus from microelectrode recordings acquired during DBS surgery with unsupervised machine learning. J Neural Eng6:0260062009
ZhangSZhouPJiangSWangWLiP: Interleaving subthalamic nucleus deep brain stimulation to avoid side effects while achieving satisfactory motor benefits in Parkinson disease: a report of 12 cases. Medicine (Baltimore)95:e55752016